FMF-06-098-1

Overview

FMF-06-098-1 is a multi-target kinase PROTAC degrader. FMF-06-098-1 can be used to target degradation kinases which degrades AAK1 , AΒL2, AURKA, AURKB, BUBIB, CDC7, CDK1 , CDK12 , CDK13 , CDK2 , CDK4 , CDk6 , CDK7 , CDK9 , CHEK1, CSNKID, EPHA1 , PER, FGFR1, GAK, IRAK4 , ITK , LIMK2 , MAP4K2, MAP4K3, MAPK6, MAPK7, MARK4, MELK , PKN3, PLK4 , PRKAA1, PTK2, PTK6, RPS6KA4, S1K2, STK35, TNK2, UHMK1, ULK1 , and WEE1 . (Pink: Ligands for Target Protein for PROTAC ligand ( HY-169396 ); Blue: VHL ligand ( HY-112078 ); Black: linker ( HY-124380 )).

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Respiratory Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Musculoskeletal and Skin Disease | Products > Disease Areas > Lipid Metabolism | Products > Disease Areas > Pulmonary Disease | Products > Disease Areas > Autoimmune Disease | Products > Disease Areas > Arthritis | Products > Disease Areas > Lung Cancer | Products > Disease Areas > Breast Cancer | Products > Disease Areas > Prostate Cancer | Products > Disease Areas > Urogenital Cancer | Products > Disease Areas > Gastric Cancer | Products > Disease Areas > Digestive System Cancer | Products > Disease Areas > Liver Cancer | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Disease Areas > Pancreatic Cancer | Products > Disease Areas > Ovarian Cancer | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Depression | Products > Disease Areas > Pain | Products > Disease Areas > Obesity | Products > Disease Areas > Lung Fibrosis | Products > Disease Areas > Rheumatoid Arthritis | Products > Signaling Pathways > PROTAC | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Autophagy | Products > Signaling Pathways > PI3K/Akt/mTOR | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Research Areas > Neurological Disease | Products > Research Areas > Metabolic Disease | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > PROTACs | Products > Signaling Pathways > Wee1 | Products > Signaling Pathways > CDK | Products > Signaling Pathways > AAK1 | Products > Signaling Pathways > ULK | Products > Signaling Pathways > MELK | Products > Signaling Pathways > Itk | Products > Signaling Pathways > IRAK | Products > Signaling Pathways > Ephrin Receptor | Products > Signaling Pathways > FGFR | Products > Signaling Pathways > MAP4K | Products > Signaling Pathways > p38 MAPK

Product Information

• Catalog No.: HY-148065
• CAS No.: 2769753-07-1
• Molecular Formula: C53H69ClN10O8S2
• Molecular Weight: 1073.76
• Purity: 98.77%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.5 mg/mL (2.33 mM); Clear solution
• Availability: In-stock

Source

Original product source